Your browser doesn't support javascript.
loading
Population Attributable Fractions of Underlying Medical Conditions for Coronavirus Disease 2019 (COVID-19) Diagnosis and COVID-19 Hospitalizations, Ventilations, and Deaths Among Adults in the United States.
Nguyen, Jennifer L; Alfred, Tamuno; Reimbaeva, Maya; Malhotra, Deepa; Khan, Farid; Swerdlow, David; Angulo, Frederick J.
Afiliación
  • Nguyen JL; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York, USA.
  • Alfred T; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Reimbaeva M; Statistical Research and Data Science Center, Pfizer Inc, New York, New York, USA.
  • Malhotra D; Global Biometrics and Data Management, Pfizer Inc, Groton, Connecticut, USA.
  • Khan F; Real World Evidence Center of Excellence, Pfizer Inc, New York, New York, USA.
  • Swerdlow D; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Angulo FJ; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
Open Forum Infect Dis ; 9(5): ofac099, 2022 May.
Article en En | MEDLINE | ID: mdl-35531382
ABSTRACT

Background:

Several underlying medical conditions have been reported to be associated with an increased risk of coronavirus disease 2019 (COVID-19) and related hospitalization and death. Population attributable fractions (PAFs) describing the proportion of disease burden attributable to underlying medical conditions for COVID-19 diagnosis and outcomes have not been reported.

Methods:

A retrospective population-based cohort study was conducted using Optum's de-identified Clinformatics Data Mart database. Individuals were followed up from 20 January 2020 to 31 December 2020 for diagnosis and clinical progression, including hospitalization, intensive care unit admission, intubation and mechanical ventilation or extracorporeal membrane oxygenation, and death. Adjusted rate ratios and PAFs of underlying medical conditions for COVID-19 diagnosis and disease progression outcomes were estimated by age (18-49, 50-64, 65-74, or ≥75 years), sex, and race/ethnicity.

Results:

Of 10 679 566 cohort members, 391 964 (3.7%) were diagnosed with COVID-19, of whom 87 526 (22.3%) were hospitalized. Of those hospitalized, 26 640 (30.4%) died. Overall, cardiovascular disease and diabetes had the highest PAFs for COVID-19 diagnosis and outcomes of increasing severity across age groups (up to 0.49 and 0.35, respectively). Among adults ≥75 years of age, neurologic disease had the second-highest PAFs (0.05‒0.27) after cardiovascular disease (0.26‒0.44). PAFs were generally higher in Black persons than in other race/ethnicity groups for the same conditions, particularly in the 2 younger age groups.

Conclusions:

A substantial fraction of the COVID-19 disease burden in the United States is attributable to cardiovascular disease and diabetes, highlighting the continued importance of COVID-19 prevention ( eg, vaccination, mask wearing, social distancing) and disease management of patients with certain underlying medical conditions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos